Lisraya’s clearance marks the first approval of a drug the Roivant subsidiary licensed from Pfizer and has since positioned ...
Researchers have successfully treated the skin diseases epidermolytic ichthyosis and ichthyosis with confetti by transplanting genetically healthy skin to inflamed areas. Their work could pave the way ...
The FDA approves Lisraya (brepocitinib), the first targeted therapy available for adults with rare skin disease ...
Though not without a bump along the way, Roivant-backed Priovant Therapeutics has pushed its dual TYK2/JAK1 inhibitor across ...
Doctors do not perform as well diagnosing skin diseases when the patient has darker skin, according to a new study. The researchers found assistance from artificial intelligence could improve doctors' ...
A bidirectional CNS–GI–skin communication network transmits signals via neuroendocrine pathways, immune mediators, and microbial metabolites, reframing acne, psoriasis, and atopic dermatitis as ...
Recognizing that skin diseases such as atopic dermatitis, psoriasis, and hidradenitis suppurativa present differently in skin of color can prevent delays in diagnosis and treatment, explained James ...
Patients with autoimmune skin diseases (ASDs) showed significantly lower risks for death after cancer treatment than those without ASDs, especially those with alopecia areata or Sjögren syndrome. A ...
There are two types of skin pigmentation disorders: hyperpigmentation, in which the skin produces too much melanin, and hypopigmentation, in which the skin produces too little melanin. Skin ...